Singapore: Japan's Teikoku Pharma has recieved USFDA approval for Docetaxel injection, a non-alcohol formula for the tre...
Singapore: Sysmex America, and Sysmex, Kobe, Japan, announced that the US FDA has cleared the Sysmex XN-Series Hematolo...
Singapore: Netzsch Japan KK acquired Bruker Corporation's thermal analysis instruments business in Japan. Netzsch Japan ...
Singapore: Boston Scientific has completed enrollment in the SuperNOVA trial - a global, single arm, prospective, multic...
Singapore: A recent report by Research and Markets estimates that global mHealth apps market will reach $6.6 billion in ...
Global biotherapeutics company CSL Behring has submitted its new drug application (NDA) to Japan's Pharmaceuticals and M...
BBK Worldwide, a leading clinical trial marketing firm, has appointed Toshio Mori to Managing Director of Operations, Ja...
W. L. Gore & Associates, Inc. (Gore) has announced that the Food and Drug Administration (FDA) has consented to the ...
Baylor Miraca Genetics Laboratories LLC (BMGL), a joint venture company between Japan-based Miraca Holdings and Baylor C...
Singapore: Global multiple myeloma treatment market value will expand from $7.3 billion in 2014 to $8.9 billion by 2021,...
Singapore: Tokyo-based Teijin Pharma, the core company of the Teijin Group's healthcare business, and Pulmagen Therapeu...
Singapore: Australia-based Cellmid plans to acquire Japanese firm Advangen that owns the FGF-5 inhibitor hair growth tec...
Materialise NV, a Belgium-based provider of 3D software and sophisticated 3D printing solutions, and a pioneer in medica...
Singapore: With a view to streamline operations and speed up new drug launches, Japan's Mitsubishi Tanabe pharma recentl...
Singapore: Japanese company Nippon Telegraph and Telephone Corporation (NTT) has developed a conductive fiber by coating...
Singapore: Daiichi Sankyo and ArQule announced that the first patient has been enrolled in the pivotal phase III METIV-...
Tokyo: Sumitomo Dainippon Pharma Co. Ltd., Center for iPS Cell Research and Application, Kyoto University (CiRA) and Hit...
Biotechnology Industry Organization (BIO) has made an announcement that the organization has joined a coalition of organ...
Tokyo: In collaboration with the Institute for Frontier Medical Sciences at Kyoto University, a team of CiRA researchers...
Singapore: Marking a major achievement in Indian biosimilar history, India's Biocon announced that close on the heels of...
Tokyo: The National Pharmaceutical Council (NPC) has inducted Takeda Pharmaceuticals USA Inc. (Takeda), a wholly-owned s...
Singapore: Vaccination will no longer be a painful process as researchers from Japan's Osaka University have developed a...
The international operation of Chinese pharmaceutical company, HUYA Bioscience International (HUYA) has expanded its Sen...
Singapore: Japan's Kowa Company and Chugai Pharmaceutical have entered into license agreement for liver cancer drug pere...
Daiichi Sankyo Company Limited has signed a license agreement with UK-based Cell Therapy Ltd for an exclusive license in...
Singapore: RaQualia Pharma and Interprotein entered into a collaborative research agreement. The partnership will focus...
Israel's Pluristem Therapeutics Inc. has announced that Japan's Pharmaceuticals and Medical Devices Agency (PMDA) has cl...
Singapore: ERT, a US-based service provider to biopharmaceutical organizations, medical device companies and contract re...
Based on a notification received from the Japanese Ministry of Health, Labour and Welfare, Daiichi Sankyo Company Limite...
Singapore: Otsuka Pharmaceutical reached an agreement to establish a joint venture (JV) in the functional food and bever...
In the biomedical sector, the combination of latest technology and a strong business model is considered to be ideal. Th...
In a step to upgrade its pharmacovigilance services, Allergan Japan has announced that the company has implemented US-he...
Singapore: Teva Pharmaceutical and Takeda Pharmaceutical has announced that the two companies have entered into a defini...
Singapore: The global aortic stent grafts market will increase in value from an estimated $1.2 billion in 2013 to just o...
Singapore: With a view to expand into the lucrative Asian markets, two major medical companies in Japan have planned to ...
For the first time, Nihon University will organize an international symposium on Medical-Engineering Collaboration with ...
Physicians at 23 brain cancer centers in Japan are now certified to provide Optune to recurrent glioblastoma patients on...
Norway-based Serendex Pharmaceuticals A/S has entered into a non-binding term sheet with a pharma company regarding Sere...
Singapore: Plasticell, the biotechnology company specialising in high throughput technologies for directed stem cell di...
OphthaliX Inc., a clinical-stage company focused on developing therapeutic products for the treatment of ophthalmic diso...
Singapore: Sigma-Aldrich's innovative biological products and services business Sigma Life Science signed an exclusive c...
Singapore: Sun Pharma has announced the acquisition of 14 established prescription brands from Novartis AG and Novartis ...
French pharma giant Sanofi has announced that the Ministry of Health, Labor and Welfare (MHLW) in Japan has granted mark...
Singapore: NextDocs, the global leader in compliance solutions for regulated industries, announced that it has expanded ...
‎Singapore: ReSearch Pharmaceutical Services (RPS) and Japan-based Asklep have formed a joint venture company (JVC...
Tokyo: Nipro Corporation, headquartered in Osaka, Japan, has signed a definitive agreement to acquire US headquartered ...
Singapore: The US arm of Japan's Eisai has entered into a worldwide collaboration with Purdue Pharma to develop and comm...
Tokyo-headquartered Dentsu Inc announced that the company's corporate venture capital arm Dentsu Ventures Global Fund ha...
Japanese pharmaceutical major Eisai Co. Ltd. has submitted applications to regulatory authorities in Japan, United State...
Singapore: Astellas Pharma and ClearPath Development Company have announced a strategic partnership to form a portfolio ...
Singapore: Eisai published the results of its 'adjunctive perampanel for refractory partial-onset seizures: randomized p...
Singapore: US FDA approved Eisai's Aciphex Sprinkle delayed-release capsules 5mg and 10mg for the treatment of gastroeso...
Singapore: BioSpectrum feels the pulse of Asia's top destinations and major players in medical tourism. Medical tour...
Singapore: GlaxoSmithKline (GSK) has announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has grant...
Japan's Taiho Pharmaceutical Co. Ltd. and France's Servier have entered into an exclusive license agreement on June 12, ...
Japanese pharmaceutical firms, Daiichi Sankyo Company Limited and UCB Japan Co. Ltd have announced that UCB Japan has ap...
Tokyo: PeptiDream Inc., a Tokyo-based biopharmaceutical company, has signed a multi-target discovery and optimization co...
Singapore: Japan's Denki Kagaku Kogyo Kabushiki Kaisha (Denka Group) recently inked a pact to acquire Germany's Icon Gen...
Osaka-headquartered Ono Pharmaceutical Co Ltd and Bristol-Myers Squibb K K have launched Orencia Subcutaneous Injection ...
Singapore: WuXi PharmaTech's small-molecule process development and manufacturing subsidiary Shanghai SynTheAll Pharmace...
Singapore: AG Mednet signed a master services agreement with Biovisiq, a Japanese imaging core laboratory (ICL), to redu...
Singulex Inc., California-based developer and provider of Single Molecule Counting technology for clinical diagnostics a...
Singapore: With a capital of $30 million, Tokyo based Chugai Pharmaceutical has announced to establish a wholly owned dr...
Singapore: Japan-based Astellas Pharma and US-based FibroGen initiated a phase II clinical study in Japan of ASP1517/FG-...
Singapore: Researchers from the RIKEN Research Centre for Allergy and Immunology in Japan have succeeded, for the first ...
The Japanese pharmaceutical market is the second largest pharma market in the world following on the close heels of the ...
Singapore: Life Technologies has signed a non-exclusive agreement with iPS Academia Japan for its induced pluripotent st...
A team of chemists and biologists at the Institute of Transformative Bio-Molecules (ITbM), Nagoya University, Japan, hav...
Singapore: Australian infectious disease therapy and vaccine development company, BioDiem, has received allowance of Jap...
Japanese pharmaceutical giant Eisai Co. Ltd. and Nihon Medi-Physics Co. Ltd. have entered into a collaboration agreement...
R-Tech Ueno Ltd, headquartered in Tokyo, has acquired the right to develop and commercialize DE-105 from Santen Pharmace...
Singapore: French biopharmaceutical company, Poxel, an innovative drug developer for type 2 diabetes, has succesfully co...
Singapore: A phase III trial evaluating the efficacy and safety of the addition of Tarceva (erlotinib) tablets to Nexava...
Singapore: US generics major Mylan has entered into a settlement agreement with OSI Pharmaceuticals, a subsidiary of Jap...
Singapore: Advanced wound care and modern wound closure products are gaining an edge over traditional wound dressings in...
Singapore: US-based Biogen, a leading developer of therapies for neurodegenerative diseases has inked a pact with Japan'...
Tokyo: Daiichi Sankyo Company, Limited has obtained approval for partial changes concerning a supplementary indication ...
NASDAQ-listed Synageva BioPharma Corp. has submitted the New Drug Application (NDA) for Kanuma (sebelipase alfa) to the ...
Tokyo: Bayer HealthCare has announced that the company has received approval in Japan for its oral Factor Xa inhibitor X...
With rapid growth of life sciences industry in Asia, we have seen many success stories over the last decade. However, an...
Singapore: Takeda Pharmaceutical has transferred its license agreement with the Japan Health Sciences Foundation (HS Fou...
Singapore: EBD Group, organizer of leading international life science partnering conferences, has announced Medtech Part...
Singapore: Japanese pharmaceutical major Santen Pharmaceutical has decided to sign an agreement with Showa Yakuhin Kakou...
Tokyo: Intercept Pharmaceuticals Inc has announced the results of a 72-week phase II dose ranging trial of obeticholic a...
Regeneron Pharmaceuticals Inc. has collaborated with Mitsubishi Tanabe Pharma Corporation (MTPC), where Regeneron will p...
Tokyo: Belgium-based Contract Research Organization (CRO) and services provider genae has incorporated 'genae Japan' in ...
Brickell Biotech Inc., a US-based clinical-stage pharmaceutical company has signed an exclusive license and development ...
September 28th witnessed the Japanese Ministry of Health, Labour and Welfare (MHLW) granting approvals to many drugs aim...
Singapore: Photonics, which recently received investments from Maxwell Biotech Venture Fund and RVC Seed Fund, has made ...
Chugai Pharmaceutical Co. Ltd. has obtained approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) for...
Tokyo: BioSpecifics Technologies Corp., a US-based biopharmaceutical company developing collagenase-based products, has ...
Singapore: Quebec's Cyclenium Pharma has signed a drug discovery collaboration agreement with Astellas Pharma in Tokyo....
Singapore: Takeda Pharmaceutical announced the acquisition of a biologics manufacturing facility located in Brooklyn Par...
Tokyo: The 28th INTERPHEX JAPAN and 9th in-PHARMA JAPAN will be held at Tokyo Big Sight from July 1st to 3rd, 2015 at th...
Singapore: According to research and consulting firm Global Data, the Japanese pharmaceutical market is poised to grow a...
The latest concern to have plagued the field of tuberculosis (TB) is the emergence of total drug resistant TB (TDR-TB). ...
Asia attracted a lot of interest from foreign multinational giants in the year 2013. This not only led to the increase i...
Founded in 1983, BBK Worldwide is a marketing consultancy firm specializing in patient recruitment for clinical R&D ...
Singapore: Japanese pharma major, Takeda Pharmaceutical Company has signed an agreement to undertake collaborative resea...
Japan's Eisai Co Ltd has announced that its US subsidiary Eisai Inc. has received approval from the US Food and Drug Adm...
